Prabhudas Lilladher target on THYROCARE
Date: 08-Nov-19
Broker: Prabhudas Lilladher
Price @ Call: 575.19
Target: 686
Recommendation: BUY
forum
THYROCARE Share Price Discussion
Thyrocare Technologies Ltd.
Sector: Pharmaceuticals and health care
Sector: Pharmaceuticals and health care
THYROCARE Share Price *
567.05 +12.75 (2.3%)
* (quote may be delayed)
THYROCARE Discussion Forum
Thyrocare Technologies (Q2, YoY) Revenue rose 11.8 percent to Rs 116.2 crore. Net profit rose 38.7 percent to Rs 35.1 crore. Ebitda rose 20.9 percent to Rs 52.1 crore. Margin stood at 44.8 percent versus 41.5 percent. Samples processed rose 5 percent to 0.52 crore. Investigations...
Read more...
Like
reply
Reply
share
Share
Buy @ 501
Target : 564
SL : 484
Like
reply
Reply (1)
share
Share
Latest replies
Target was done. High 600
Stocks in the news: Biocon, Petronet LNG, Hero Moto, Alkem Lab, PNB, Cipla, Torrent Pharma
Petronet LNG | Hero MotoCorp | Torrent Pharmaceuticals| Reliance Capital | HEG | PNB and Canara Bank are among stocks which are in news today.
Petronet LNG | Hero MotoCorp | Torrent Pharmaceuticals| Reliance Capital | HEG | PNB and Canara Bank are among stocks which are in news today.
Moneycontrol
Like
reply
Reply
share
Share
Buy Thyrocare Technologies; target of Rs 595: Prabhudas Lilladher
Prabhudas Lilladher is bullish on Thyrocare Technologies has recommended buy rating on the stock with a target price of Rs 595 in its research report dated August 14, 2019.
Prabhudas Lilladher is bullish on Thyrocare Technologies has recommended buy rating on the stock with a target price of Rs 595 in its research report dated August 14, 2019.
Moneycontrol
Like
reply
Reply
share
Share
Thyrocare Technologies Q1 PAT may dip 6.5% YoY to Rs. 22.1 cr: Prabhudas Lilladher
Like
reply
Reply
share
Share
Stocks in the news: Tata Motors, BPCL, Cipla, Alkem Lab, Fortis Health, TRF
Like
reply
Reply
share
Share
Stocks in the news: Tata Motors, BPCL, Cipla, Alkem Lab, Fortis Health
Like
reply
Reply
share
Share
Q. Why this stock is going down any idea?
Like
reply
Reply
share
Share
Thyrocare Technologies Q4 PAT seen up 18.1% YoY to Rs. 29.7 cr: Prabhudas Lilladher
_21405259.jpg)
Like
reply
Reply
share
Share
Metropolis to focus on wellness, specialty tests & acquisitions to grow biz
Like
reply
Reply
share
Share
Buy Thyrocare Technologies; target of Rs 795: Prabhudas Lilladher
Like
reply
Reply
share
Share
Buy Thyrocare Technologies; target of Rs 796: Prabhudas Lilladher
Like
reply
Reply
share
Share
- NewsBotSep 23 1:58 PMStocks in the news: Biocon, Petronet LNG, Hero Moto, Alkem Lab, PNB, Cipla, Torrent PharmaMoneycontrolNewsBotAug 19 7:38 PMBuy Thyrocare Technologies; target of Rs 595: Prabhudas LilladherMoneycontrolNewsBotJul 12 10:53 PMThyrocare Technologies Q1 PAT may dip 6.5% YoY to Rs. 22.1 cr: Prabhudas LilladherNewsBotMay 20 1:33 PMStocks in the news: Tata Motors, BPCL, Cipla, Alkem Lab, Fortis Health, TRFNewsBotMay 20 1:23 PMStocks in the news: Tata Motors, BPCL, Cipla, Alkem Lab, Fortis HealthNewsBotApr 12 6:58 PMThyrocare Technologies Q4 PAT seen up 18.1% YoY to Rs. 29.7 cr: Prabhudas LilladherNewsBotMar 29 2:48 AMMetropolis to focus on wellness, specialty tests & acquisitions to grow bizNewsBotFeb 18 7:47 PMBuy Thyrocare Technologies; target of Rs 795: Prabhudas LilladherNewsBotNov 15 6:07 PMBuy Thyrocare Technologies; target of Rs 796: Prabhudas Lilladher
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.